Episode 314: APCCC 2024 Cardiovascular risks with hormone therapy in prostate cancer by The Uromigos
Thomas Suter and Chuck Ryan discuss identification and management of cardiovascular disease for patients starting therapy for prostate cancer.
Thomas Suter and Chuck Ryan discuss identification and management of cardiovascular disease for patients starting therapy for prostate cancer.
A meta-analysis found that low serum vitamin D levels significantly increase the risk of developing type 2 diabetes in older adults, even after adjusting for…
MGUS and Autoimmunity- Myth or Reality 1 Manni Mohyuddin, MD Assistant Professor UU-HCI Multiple Myeloma Program
Plant-based diets are increasingly embraced for their marked health benefits for cardiometabolic diseases and their positive environmental impact. However, the relationship between such diets and…
Blood Cancers Today provides hematologists and oncologists with news, education, and information relevant to their patients and practices, featuring exclusive expert interviews.
AbstractBackgroundTotal coronary atherosclerotic plaque activity across the entire coronary arterial tree is associated with patient-level clinical outcomes.ObjectivesWe aimed to investigate whethe…
Dr. Doshi and colleagues designed an analysis of patients with metastatic ChRCC to better understand first-line therapy.
Postural Orthostatic Tachycardia Syndrome (POTS) is a heterogenous disorder that presents with positional tachycardia, amongst many other symptoms. Evidence for treatment options remains limited,
A meta-analysis of over 730,000 individuals indicates that high broccoli consumption is linked to lower cancer prevalence, though more robust research is needed to confirm…